Navigation Links
Oncolytics Biotech Inc. Announces 2008 First Quarter Results
Date:4/30/2008

$ $ $

-------------------------------------------------------------------------

Changes in:

Accounts receivable (5,014) 33,055 (85,099)

Prepaid expenses 98,822 (143,417) (161,478)

Accounts payable and accrued

liabilities (69,127) 232,940 2,752,100

-------------------------------------------------------------------------

Net change in non-cash working

capital 24,681 122,578 2,505,523

Portion related to investing

activities 23,078 (19,300) (22,543)

-------------------------------------------------------------------------

Net change associated with

operating activities 47,759 103,278 2,482,980

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Other Non-Cash Items

Cumulative

from

Three Month Three Month inception

Period Period on April 2,

Ended Ended 1998 to

March 31, March 31, March 31,

2008 2007 2008

$ $ $

-------------------------------------------------------------------------

Foreign exchange loss - - 425,186

Donation of medical equipment - - 66,069

Loss on sale of Transition

<
'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... January 14, 2014 EquitiesIQ, a leading ... (OTCQB: ALQA). Alliqua is an emerging biomedical company acquiring, ... wound care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... a seasoned management team and Board, which launched the ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Global ... developing innovative information technology solutions for patients, physicians, ... care stakeholders, announced today the signing of a ... Food and Drug Administration (FDA). This initiative ...
(Date:1/14/2014)... Kerr Corporation, a leading manufacturer of innovative dental products, ... dual arch impressions on its dental blog. , ... entry serves up a list of tips to help dentists ... Dr. David Little as he crafts a porcelain crown using ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... -- The Wisconsin Department of Commerce (Commerce) has ... the new Angel Investor and Venture Fund Tax Credit ... for investors and will help us attract qualified angels ... testing of our technology," said Larry Wells, CEO of ...
... CHICAGO As witnessed by the BIO 2005 meeting ... beyond its U.S. roots has really taken flight. The company ... & Young in its annual report on biotechnology. , ,This ... meeting. This years report, which carries the appropriate title Beyond ...
... Madison, Wis . - The average citizen may think Gov. ... Frazier whenever they step into the boxing ring of politics. ... taken place in the Capitol over the past two and ... correct. , ,Not entirely correct, however, as evidenced by some ...
Cached Biology Technology:Globalization of biotech industry is a decidedly worldwide phenomenon 2Globalization of biotech industry is a decidedly worldwide phenomenon 3State tax compromises prove that partisanship can be set aside for a while 2State tax compromises prove that partisanship can be set aside for a while 3
(Date:4/24/2014)... New Rochelle, NY, April 24, 2014GEN Publishing recently ... semi-monthly digital publication focusing on the application of ... such as next-gen sequencing, are beginning to transform ... science research over the past decade-and-a-half. , "GEN,s ... use of pharmacogenomics, genomics, metabolomics, transcriptomics, etc. etc. ...
(Date:4/24/2014)... NY, April 24, 2014D-ribose is a commercially important ... and as a starting compound for synthesizing riboflavin ... Escherichia coli to increase the bacteria,s ability ... achieving more efficient industrial-scale production of this valuable ... Industrial Biotechnology , a peer-reviewed journal from Mary ...
(Date:4/24/2014)... the Scientific Reports journal. , CSIC researcher Carles ... of CSIC and Pompeu Fabra University-UPF), explains: "When the Y ... that it did not match with the DNA recovered from ... genome and to make a functional interpretation in order to ... , The functional genome analysis was based on two ...
Breaking Biology News(10 mins):The blood preserved in the pumpkin did not belong to Louis XVI 2
... German . , Mucosal epithelia do not have ... viruses like hepatitis C, herpes, the adenovirus or polio, and ... as the human immunodeficiency virus HIV, still manage to enter ... occurs on a molecular level has been a mystery. Three ...
... new study reveals how enzymes in the honey ... the honey bee hive. This is the first study to ... insect to tolerate exposure to these potentially deadly compounds. ... Academy of Sciences . Previous studies have shown that ...
... University of Minnesota Medical School and College of Biological ... sex must be maintained throughout life. The research team, ... U of M Department of Genetics, Cell Biology and Development, ... causes male cells in mouse testis to become female cells. ...
Cached Biology News:Scavenger cells accomplices to viruses 2Team shows how the honey bee tolerates some synthetic pesticides 2U of M researchers discover gene required to maintain male sex throughout life 2
... are derived from Paraffin embedded tissue blocks, ... procedures to ensure the highest quality. Tissues ... one block, sectioned at a thickness of ... Sections are large (3-5 mm in diameter) ...
... are derived from Paraffin embedded tissue blocks, ... procedures to ensure the highest quality. Tissues ... one block, sectioned at a thickness of ... Sections are large (3-5 mm in diameter) ...
... derived from frozen embedded tissue blocks, which ... to ensure the highest quality. Tissues of ... block, sectioned at a thickness of 7microns ... large (3-5mm in diameter) in comparison to ...
... from frozen embedded tissue blocks, which are ... ensure the highest quality. Tissues of each ... sectioned at a thickness of 7microns and ... (3-5mm in diameter) in comparison to core ...
Biology Products: